Chromosome Microarray (CMA) Detection - CapitalBio Technology Co., Ltd.

Testing Content

Detection of 23 pairs of chromosomal aneuploidy and whole genome chromosomal abnormalities greater than 100kb.

Testing Method

Sample Requirements

Venous Blood: Collect 4mL, store at 2-8°C. Transport with biological ice packs (2-8°C) within 72 hours. Use an EDTA anticoagulant tube.

Reporting Cycle

10 working days

Clinical Application Overview

1. Chromosomal Abnormalities Screening: Screen for chromosomal abnormalities in children with developmental issues, intellectual disabilities, multiple malformations, and other illnesses. Provide guidance for disease confirmation and treatment.

2. Genetic Causes Identification: Identify genetic causes of recurrent miscarriage and infertility. Offer follow-up fertility guidance and recommendations.

PREV: Chromosome Microarray (CMA) Detection (3)

NEXT: Chromosome Microarray (CMA&STR) Detection 2.0

Related IVD Products

Related News Of IVD Technology

What Are the Diagnostic Methods for Breast Cancer?April 4, 2023Breast cancer has become a terrifying disease that kills female friends with increasing clinical incidence rate. It not only harms women's health but also has a great impact on our normal life. So...view
Navigating the Landscape of Different NGS Platforms: A Comprehensive GuideJune 5, 2024he development of next-generation sequencing (NGS) over the past 15 to 20 years has seen multiple technologies rapidly leapfrogging each other’s milestones to sequence more DNA faster, cheaper, and m...view
Why Choose Microarrays over Other Technologies?November 10, 2023Microarrays are becoming an increasingly popular choice for biologists and researchers worldwide. With the help of advanced technology, these arrays provide a cost-effective and efficient way to analy...view
Prostate Cancer (PCA) Is A Difficult Disease To UnderstandJune 28, 2022Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. On the other hand, non-genetic intra-t...view
CapitalBio: Advancing Breast Cancer Research with Microarray ScannersFebruary 7, 2024Introduction to CapitalBio and BRCA Gene ResearchCapitalBio, a global leader in biotechnology, is making significant strides in breast cancer research with its advanced microarray scanners. These inst...view
Unlocking the Genetic Code: How Clinical WES Is Revolutionizing Medical ResearchJanuary 4, 2024In recent years, significant advancements in medical research have led to the emergence of clinical Whole Exome Sequencing (WES) as a game-changer in unraveling the secrets of the human genome. Clinic...view